A Statewide Population-Linkage Study on the Impact of Atrial Fibrillation on Outcomes in 145,293 Patients Admitted With COVID-19

Atrial fibrillation (AF) is common in COVID-19 patients. The impact of AF on major adverse cardiovascular events (MACE defined as all-cause mortality, myocardial infarction, ischaemic stroke, heart failure or revascularisation), recurrent admissions with AF, and venous thromboembolism in patients hospitalised with COVID-19 is not well-defined.

Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: J. Ne, C. Chow, A. Yan, I. Rubenis, S. Virk, V. Chow, K. Hyun, L. Kritharides, D. Brieger, A. Ng Source Type: research